Southern African HIV Clinicians Society

Southern African HIV Clinicians Society

Interactive Data Dashboards

Track the HIV & TB response

Key indicators, province breakdowns and downloadable graphs.

  • Thousands of kids with HIV switched to newer treatment

    A child-friendly formulation of the antiretroviral drug dolutegravir was first included in the country’s HIV treatment guidelines in 2023. New estimates suggest that most children aged one to four living with HIV have now been switched to the drug, reports Elri Voigt.

    ·

  • Integrating HIV and NCD care is critical but not straight-forward, clinicians say

    With the remarkable success of antiretroviral treatment people living with HIV in South Africa are generally living much longer than they did two decades ago. As a result, more people with HIV are also now living with non-communicable diseases (NCDs) such as diabetes and hypertension. Accordingly, the need to better integrate HIV and NCD services…

    ·

  • The court ruling that gives qualifying pharmacists the green light to provide HIV and TB meds without a script

    Specially trained and accredited pharmacists in South Africa will now be allowed to dispense medicines to prevent HIV and TB and to treat uncomplicated HIV without a doctor’s script. This is because the North Gauteng High Court this week ruled against an application by a private doctors’ association attempting to block the initiative. Catherine Tomlinson…

    ·

  • Over 4.7m people in SA placed on new HIV med in four years

    In what is likely one of the largest treatment rollouts in South African history, well over four million people living with HIV have started taking the antiretroviral dolutegravir since its introduction around four years ago. Now, according to a recent study published in the Lancet medical journal, use of dolutegravir in South Africa is associated…

    ·

  • Struggle for migrant health rights still far from over after landmark judgment 

    In a landmark court decision, the Gauteng High Court recently confirmed the rights of all pregnant and lactating women and children under age six to access services for free at all levels of care. The court order sets a good precedent for migrant health rights going forward, writes Mbali Baduza and Kholofelo Mphahlele as they…

    ·

  • Experts welcome new HIV treatments for kids

    New child-friendly formulations of several important antiretroviral medicines were recently approved by the South African Health Products Regulatory Authority. Thabo Molelekwa asks what this means for children living with HIV in South Africa and how long it will take for these medicines to become widely available.

    ·

  • Over 3million people on new HIV drug, but not all smooth sailing

    In 2019, the Department of Health started providing the antiretroviral drug dolutegravir as part of HIV treatment in the public sector. Three years later, close to 3.2 million people in South Africa are taking dolutegravir every day. Even so, the rollout of dolutegravir hasn’t all been smooth sailing. Elri Voigt investigates how the massive undertaking…

    ·

  • What will it take to bring HIV prevention injections to SA’s clinics?

    An antiretroviral injection administered every two months has been shown to be highly effective in preventing people from getting HIV in two large trials. Catherine Tomlinson asks what needs to happen before these injections become available to people in South Africa.

    ·

  • HIV docs win quack HIV gel case

    The South Gauteng High Court this week ruled in favour of the SA HIV Clinicians Society in its legal battle with a doctor who promoted a product marketed as Dr Hugh’s Dermo Blue Pre-sex Protection Gel, which claimed to prevent HIV infection.

    ·